In part 2 of this series, Andrea Cercek, MD, discusses the clinical findings, molecular drivers/alterations, and further research for "Early On-Set Colorectal Cancer: A Biologically Distinct Threat…
In part 1 of this video series, Andrea Cercek, MD, discusses the background and possible association of hereditary/environmental factors in early-onset CRC.
Julio Garcia-Aguilar, MD, PhD, provided insight on how nonoperative management of rectal cancer is evolving at the virtual 2020 Great Debates & Updates in Gastrointestinal Malignancies meeting.
Christopher Crane, MD, Memorial Sloan Kettering Cancer Center, New York, NY discusses proof of principle for treating oligometastatic colorectal cancer at the virtual 2020 Great Debates and Updates…
Tanios Bekaii-Saab, MD, talks about the evolving therapy landscape of MSI-high colon cancer.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Jeffrey A. Meyerhardt, MD, MPH, provided an update on the latest approaches for the first- and next-line treatment of CRC.
Scott Kopetz, MD, PhD, FACP, discusses using targeted therapy earlier in the treatment of patients with CRC and BRAF V600E mutation.
At the 2019 Great Debates & Updates in GI Malignancies meeting, Mark A. Lewis, MD, provided an update on the biologically distinct threat of early-onset CRC.